Gene therapy for cancer - In the dock, blown off course or full speed ahead?

Cancer and Metastasis Reviews

Volumn 15, Issue 3, 1996, Pages 283-286

  Vile, Richard C ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

cancer; gene therapy

Indexed keywords

CANCER; GENE THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 0029843394     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00046342     Document Type: Review

References (42)

1. Blaese RM et al.: T-lymphocyte-direcled gene therapy for ADA-SCID: initial trial results after 4 years. Sci 270: 475-480, 1995
2. Knowles MR, K.W. H, Zou Z, J.C. O. Noah TL, Hu P-C, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR, Grossman M, Wilson JM, Johnson LG, Boucher RC: A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. New Engl J Med 333: 823-831, 1995
3. Grossman M et al.: A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolemia. Nat Med 1: 1148-1154, 1995
4. Mendell JR et al.: Myoblast transfer in the treatment of Duchenne's muscular dystrophy. New Engl J Med 333:832-838, 1995
5. Bordignon C et al.: Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Sci 270: 470-475, 1995
6. Leiden JM: Gene therapy - promise, pitfalls and prognosis. New Engl J Med 333: 871-872, 1995
7. Brenner MK: Human somatic gene therapy, progress and problems. J Int Med 237: 229-239, 1995
8. Verma I: Gene therapy: Hopes, hypes and hurdles. Mol Med 1: 2-3, 1994
9. Friedmann T: The promise and overpromise of human gene therapy. Hum Gen Ther 1: 217-218, 1994
10. Weatherall DJ: Scope and limitations of gene therapy. Brit Med Bull 51: 1-11, 1995
11. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends in Genetics 9: 138-141, 1993
12. Vile RG, Russell SJ: Gene transfer technologies for the gene therapy of cancer. Gen Ther 1: 88-98, 1994
13. Dillon N: Regulating gene expression in gene therapy. Trends in Biotechnology 11: 167-173, 1993
14. Collins FS: Cystic fibrosis: molecular biology and therapeutic implications. Sci 256: 774-779, 1992
15. Mulligan RC: The basic science of gene therapy. Sci 260: 926-932, 1993
16. Anderson WF: Human gene therapy. Sci 256: 808-813, 1992
17. Friedmann T: Gene therapy of cancer through restoration of tumor-suppressor functions? Cane (Suppl) 70: 1810-1817, 1992
18. Mercola D, Cohen JS: Antisense approaches to cancer gene therapy. Cane Gene Ther 2: 47-59, 1995
19. Moolten FL: Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cane Gene Ther 1: 279-287, 1994
20. Pardoll DM: Paracrine cytokine adjuvants in cancer immunotherapy. Ann Rev Immunol 13: 399-415, 1995
21. Deisseroth AB, Holmes F, Hortobagyi G, Champlin R: Clinical Protocol: Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal haematopoietic cells for chemoprotection during the therapy of breast cancer: A pilot trial. Hum Gene Ther 7: 401-416, 1996
22. Crystal RG: Transfer of genes to humans: early lessons and obstacles to success. Sci 270: 404-410, 1995
23. Hodgson C: The vector void in gene therapy. Biotechnol 13: 222-225, 1995
24. Jolly D: Viral vector systems for gene therapy. Cane Gene Ther 1: 51-64, 1994
25. Ahmad I, Longenecker M, Samuel J, Allen TM: Antibody targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cane Res 53: 1484-1488, 1993
26. Ali M, Lemoine NR, Ring CJA: The use of DNA viruses as vectors for gene therapy. Gene Ther 1: 367-384, 1994
27. Findeis MA, Merwin JR, Spitalny GL, Chiou HC: Targeted delivery of DNA for gene therapy via receptors. Trends in Biotechnology 11: 202-205, 1993
28. Heiser WC: Gene transfer into mammalian cells by particle bombardment. Analytical Biochemistry 217: 185-196, 1994
29. Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE: Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proceedings of the National Academy of Sciences U.S.A. 90: 11307-11311, 1993
30. Stribling R, Brunette E, Liggitt D, Gaensler K, Debs R: Aerosol gene delivery in vivo. Proceedings of the National Academy of Sciences U.S.A. 89: 11277-11281, 1992
31. Clayman GL, El-Naggar AK, Roth JA, Zhang W-W, Goepfert H, Taylor DL, Lui T-J: In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma. Cancer Res 55: 1-6, 1995
32. Georges RN, Mukhopadhyay T, Zhang Y, Yen N, Roth JA: Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Cancer Res 53: 1743-1746, 1993
33. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Sci 256: 1550-1552, 1992
34. Chen S-H, Shine HD, Goodman JC, Grosman RG: Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proceedings of the National Academy of Sciences U.S.A. 91: 3054-3057, 1994
35. Vile RG, Nelson JA, Castleden SC, Chong H, Hart IR: Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Res 54: 6228-6234, 1994
36. Chen S-H, Chen XHL, Wang Y, Kosai K-I, Finegold MJ, Rich SS, Woo SLC: Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proceedings of the National Academy of Sciences U.S.A. 92: 2577-2581, 1995
37. Hurford JRK, Dranoff G, Mulligan RC, Tepper RI: Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nat Gen 10: 430-435, 1995
38. Plautz GE, Yang Z-Y, Wu B-Y, Gao X, Huang L, Nabel GJ: Immunotherapy of malignancy by in vivo gene transfer into tumors. Proceedings of the National Academy of Sciences U.S.A. 90: 4645-4649, 1993
39. Rosenberg SA, Packard BS, Aebersold PM et al.: Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma, special report. N Engl J Med 319: 1676-1680, 1988
40. Townsend SE, Allison JP: Tumour rejection after direct costimulation of CD8 + T cells by B7-transfected melanoma cells. Sci 259: 368-370, 1993
41. Tepper RI, Mule JJ: Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5: 153-164, 1994
42. Ram Z et al.: Summary of results and conclusions of the gene therapy of malignant brain tumors: clinical study. J Neurosurg 82: 343A, 1995